Ignite Creation Date:
2024-05-06 @ 6:33 PM
Last Modification Date:
2024-10-26 @ 2:50 PM
Study NCT ID:
NCT05703971
Status:
RECRUITING
Last Update Posted:
2024-05-20
First Post:
2023-01-19
Brief Title:
Quaratusugene Ozeplasmid Reqorsa and Atezolizumab Maintenance Therapy in ES-SCLC Patients
Sponsor:
Genprex Inc
Organization:
Genprex Inc